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Abstract
A middle aged primigravida was managed at the University of Nigeria Teaching Hospital, Enugu,
Nigeria for a pituitary macroadenoma. She was admitted at 33 weeks gestational age following a
history of blurred vision and generalized headache, worse on bending down. After neurological
consultation and investigations, a diagnosis of pituitary macroadenoma with mass effect was
entertained. A plan for neurosurgery after delivery was made and the patient put on bromocriptine
to reduce tumour size. Premature labour at 35 weeks resulted in caesarean delivery of a live baby.
She was managed in the intensive care unit for three days where oral bromocriptine was resumed
before she was transferred to the postnatal ward. Within ten hours of the transfer, she developed
accelerated hypertension with encephalopathy and had a cardiac arrest shortly afterwards. This
rare case highlights both the possible role of bromocriptine as a cause of postpartum hypertension
and the possible development of a sudden catastrophic intramoural infarction or hemorrhage
(pituitary apoplexy) in a patient with a macroadenoma.
Introduction
The preoperative management of patients with pituitary
tumors presenting for surgery requires careful preopera-
tive assessment and meticulous pre and postoperative
management especially so in the pregnant patient. Partic-
ular problems in these parturient have to do with the pri-
mary hormonal hyper secretion and its complications,
and to the mass effect of the tumours [1].
Knowledge of the normal physiology and anatomy of the
pituitary gland is important to allow an understanding of
path physiological effects relevant to anesthesia and of the
potential complications that might arise perioperatively
[1].
Anaesthesia for pituitary disease is a highly specialized
area and because the reported cases are few [2], especially
during pregnancy, extensive experience in this area is
often lacking. Prolactinomas are the commonest pituitary
tumors complicating pregnancy. Based on their size prol-
actinomas are classified into macroadenoma (>1 cm) or
micro adenoma (< 1 cm). In this case, we report the pre-
operative management of a parturient with a macroade-
noma presenting for caesarean delivery at the gestational
age of 34 weeks and five days.
Case presentation
A 30 year old nulliparous Nigerian woman of the Igbo
tribe presented for antenatal care at 24 weeks gestational
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age. She had two visits to the hospital before she pre-
sented to the hospital as an emergency. After a review by
the obstetrician, she was admitted to the antenatal ward
and a consult sent to the neurologist for a review.
The patient gave a two year history of blurring of vision,
followed a month later by generalized headache that was
worse on bending. The headache had intensified since
becoming pregnant. Of recent there had been associated
vomiting. There was also a history of menstrual irregular-
ities, urinary frequency and protrusion of the right eye.
She did not report any weakness in the limbs or trauma to
the head or eye. She had visited an ophthalmologist
where she was treated on outpatient basis.
Physical examination revealed a young woman in painful
distress, conscious and well oriented. She was not pale,
icteric or febrile to touch. Blood pressure on admission
was 120/80 mmHg and pulse rate was 76 beats per
minute, regular and of good volume.
Examination of the central nervous system revealed prop-
tosis of the left eye and a blind right eye. There was tem-
poral visual loss with reduced acuity in the left eye.
Fundoscopy showed established optic atrophy in the right
eye with early optic atrophy changes in the left eye. Other
cranial nerves were intact with no sign of meningeal irri-
tation. There were no asymmetries in the limbs. The pos-
sibility of an intracranial space occupying lesion was
entertained.
Relevant investigations were ordered. A computerized
tomography (CT) scan of the brain showed a large pitui-
tary tumour (> 10 mm) with pressure effects, occluding
the anterior horn of the left lateral ventricle. The other
ventricles were dilated.
The results of other investigations were as follows - serum
prolactin 250 ng/ml (6.0 - 24), serum T3 2.4 ng/ml (0.6 -
1.6), serum cortisol 310 ng/ml (50 - 230) and fasting
blood sugar 69 mg/dl (65 - 110). Abdominopelivic ultra-
sound scan revealed a live singleton fetus at 33 weeks with
cephalic presentation and anterior placenta. The fetal
heart rate was 130/minute.
A diagnosis of pituitary macroadenoma with mass effect
was made.
The symptoms gradually regressed with good clinical
improvement. After sixteen days of admission, the patient
went into premature labor at 34 weeks and five days. After
a review by the obstetricians, she was booked for emer-
gency caesarean section and the anesthetists were
informed.
Because the CT scan showed evidence of raised intracra-
nial pressure, general anesthesia with the relaxant tech-
nique was used with sodium thiopentone, non-
depolarizing muscle relaxant, opioid analgesics and oxy-
gen/air. Sodium thiopentone was used for maintenance of
anesthesia in intermittent bolus doses as that would pre-
vent further rise in intracranial pressure and the possible
risk of bleeding if the available volatile agent, halothane
was used. Anesthesia by the corresponding author was
uneventful and the patient recovered satisfactorily. She
was taken to the intensive care unit for postoperative care
and close monitoring.
She recovered full consciousness in ICU. On the second
postoperative day, she was resumed on oral bromocrip-
tine with the following postoperative drugs; ampiclox,
metronidazole, pethidine and promethazine. The follow-
ing day, she had complained of restlessness before she was
discharged to the ward on the third postoperative day by
2 pm in fairly satisfactory condition. Later that day at
about 11:30 pm, the duty doctors were called to see the
patient on account of sudden and sustained rise in blood
pressure. On examination she was unconscious and afe-
brile. The blood pressure was 210/110 mmHg and the
pulse rate was 150 beats per minute.
A diagnosis of accelerated hypertension with encephalop-
athy was made and the following drugs prescribed; intra-
venous bolus dose of hydralazine 5 mg stat, then 40 mg in
a litre of 5% dextrose in water to run at ten drops per
minute with quarter hourly monitoring of blood pressure.
About 15 minutes later the patient started gasping and
went into cardiac arrest. Attempts at resuscitation failed.
An autopsy was not done.
Discussion
Prolactin secreting adenomas are the most commonly
encountered pituitary tumours in women of child bearing
age [3]. Because it interferes with the hypothalamic - pitu-
itary - ovarian axis at various levels, it is believed to be
responsible for about a third of all cases of female infertil-
ity.
The relationship between pregnancy and the growth of
prolactinomas was first identified in the 1970s when it
was observed that in women who had recovered fertility
following treatment with ovulation inducing drugs or
bromocriptine, pregnancy was associated with pituitary
growth [4]. Some of these women later developed visual
defects that required surgery while others had their vision
restored to normal spontaneously after delivery [1].
Molitch has summarized the recent findings on the effects
of pregnancies on prolactinomas [5]. While the risk of
clinically significant enlargement for women with micro-Cases Journal 2009, 2:9117 http://www.casesjournal.com/content/2/1/9117
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prolactinomas is 1.3%, the risk of enlargement for women
with untreated macroprolactinomas is 23.2%. There is a
less likely chance of symptomatic growth during preg-
nancy after shrinkage with bromocriptine even after it is
discontinued [5].
It has been suggested that re-introduction of bromocrip-
tine is the preferred treatment for the pregnant woman
with prolactinoma who becomes symptomatic. It has
been reported that most cases quickly show regression of
symptoms such as headache and signs (visual field
changes) of tumour enlargement.
The history in this case appears inadequate as there is no
indication of a possible use of bromocriptine before preg-
nancy as there was a positive history of menstrual irregu-
larities.
There was clinical improvement in our patient after intro-
duction of bromocriptine up to the time she went into
labor at nearly 35 weeks. An emergency caesarian section
was carried out under general anesthesia with the delivery
of a live baby with an Apgar score of 8 after 5 minutes.
She was transferred to the intensive care unit for close
monitoring and observation. She had a bout of pyrexia on
the second postoperative day with a return to normal tem-
perature after administration of an antipyretic. The patient
had been screened for malarial parasites and treated for
malaria before caesarean delivery. Other events were une-
ventful except for a complaint of restlessness, before she
was discharged to the ward. Within the next ten hours, she
had developed accelerated hypertension and died. Bro-
mocriptine shares with other ergot alkaloids the property
of vasoconstriction, with the potential for serious tissue
injury [6]. Hypertension [7] and cardiac injury has been
associated with bromocriptine use in the postpartum
period [8].
Because of these rare but serious side effects which may
also include cerebral angiopathy, strokes and seizures, its
use is not advocated in the postpartum period [9]. Per-
haps a lower starting dose of bromocriptine should have
been used.
It was for this reason that oxytocin was used for uterine
contraction following caesarean delivery in order to avoid
the use of egometrine, another ergot alkaloid.
Though an autopsy was not carried out in this patient, a
catastrophic complication of a pituitary tumour (espe-
cially a macroadenoma) related to sudden intratumoural
infarction or haemorrhage (pituitary apoplexy) [10]
might be a possibility.
Conclusion
Prolactinomas are reportedly rare during pregnancy and
are known to respond to treatment with bromocriptine. If
the pregnancy is far from term and the clinical features are
unresponsive to bromocriptine, surgery is advised. If near
term, the woman is delivered before neurosurgery.
Anesthesia for caesarean delivery and ICU care were fairly
uneventful. The use of dopamine agonists like bromocrip-
tine in the postpartum period should be reviewed. This
rare case also highlights the pitfalls that clinicians may
encounter in the management of such patients especially
when related literature from the region is scare.
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